Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramosetron vs Ondansetron for Established PONV
NCT03017222Completed
- Sponsor
- Yonsei University
- Start
- Sep 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of ramosetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yonsei University. Primary endpoint: Rate of patients exhibiting complete response at 24 hours. Started Sep 2015; status: completed.
02
Drugs
ramosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03017222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017222.